Werling, PhD, D. Genome-Wide De Novo Risk Score Implicates Promoter Variation in Autism Spectrum Disorder.
An JY, Lin K, Zhu L, Werling DM, Dong S, Brand H, Wang HZ, Zhao X, Schwartz GB, Collins RL, et al. (2018). Genome-wide de novo risk score implicates promoter variation in autism spectrum disorder. Science, 14;362(6420). pii: eaat6576. doi: 10.1126/science.aat6576.